influenza – Global Health Press

GHP News Latest Science

Literature update ViVa week 35-2026

1. GBS vaccine candidate clears a first key hurdle in HIV-endemic Africa A Ugandan phase 2 trial shows a hexavalent GBS6 vaccine candidate is safe and equally immunogenic in pregnant women with and without HIV, offering...

3 September, 2026

8 min read

GHP News Latest Science

Dual influenza subtype positivity is linked to more severe pneumonia, but is it true co-infection or a dataset artifact?

Summary This retrospective single-center study (Guangyuan, China, September 2024–March 2025) linked clinical and BALF targeted-NGS pathogen data in 97 adults hospitalized with influenza-associated CAP. There were 51...

21 July, 2026

2 min read

GHP News Latest Science

ViVa 28 feature: Universal influenza vaccines – more than just “broader immunity”

Why We Need a Universal Influenza Vaccine Every year, millions of people roll up their sleeves for a flu shot, and every year, that same shot needs reformulating. This isn’t bureaucratic inefficiency — it’s...

15 July, 2026

5 min read

GHP News Latest Science

Evidence brief -Week 12

Brazil develops and rolls out single-dose dengue vaccine This article signals a major advance toward operationally feasible dengue vaccination, especially in high-burden, access constrained settings, and may preview...

25 March, 2026

20 min read

GHP News Latest Science

Estimating influenza vaccine effectiveness against laboratory-confirmed influenza using linked public health information systems, California, 2023–2024 season

Summary This study evaluates the effectiveness of seasonal influenza vaccination in California by analyzing data from mandatory statewide public health reporting systems for influenza laboratory results and administered...

19 November, 2025

4 min read

GHP News Latest Science

Highly effective prevention of myocardial infarction: Benefits of influenza vaccination

The Influenza vaccination After Myocardial Infarction (IAMI) trial is a pivotal, multicenter, randomized, double-blind, placebo-controlled study designed to assess the clinical benefit and safety of influenza...

11 November, 2025

5 min read

GHP News Latest Science

Package inserts should be balanced: A call to equally mention risks and benefits

Using an innovative study design, Fröbert et al. report that influenza vaccination within 72 hours of hospital admission for myocardial infarction significantly reduced all-cause and cardiovascular mortality over 12...

11 November, 2025

5 min read

GHP News Latest Science

Updated evidence for COVID-19, RSV, and Influenza vaccines for 2025–2026

SummaryThis comprehensive systematic review by leading US researchers, published in the New England Journal of Medicine, synthesizes new evidence on the effectiveness and safety of COVID-19, RSV, and influenza vaccines...

4 November, 2025

3 min read

Asia GHP News Outbreak Countries

Current influenza situation in Taiwan — October 2025

Key points AH3N2 is now the dominant influenza strain; influenza activity and severe complications are increasing. Severe complications and mortality predominantly affect adults aged ≥50 years, particularly those ≥65...

15 October, 2025

2 min read

GHP News Latest Science

The Japanese experience with vaccinating schoolchildren against influenza

The landmark study by Reichert et al. (2001) systematically analyzed the impact of Japan’s national policy to vaccinate schoolchildren against influenza on overall and pneumonia/influenza-associated mortality, spanning...

9 September, 2025

3 min read

Tag - influenza